{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:09:56Z","timestamp":1757617796688,"version":"3.44.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08187-7","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T23:49:25Z","timestamp":1745279365000},"page":"3775-3782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population preventable fraction of total multiple sclerosis risk associated with non-specific effects of vaccinations against hepatitis B virus and influenza A and B viruses in a middle eastern country"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1261-788X","authenticated-orcid":false,"given":"Saeed","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel El","family":"Muzaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasem Y.","family":"Al-Hashel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alroughani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"1","key":"8187_CR1","first-page":"43","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Mult Scler 4(1):43","journal-title":"Mult Scler"},{"key":"8187_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.msard.2017.12.015","volume":"20","author":"MH Harirchian","year":"2018","unstructured":"Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S (2018) Worldwide prevalence of Familial multiple sclerosis: A systematic review and meta-analysis. Multiple Scler Relat Disorders 20:43\u201347","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"8187_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13(1):25\u201336","journal-title":"Nat Rev Neurol"},{"key":"8187_CR4","doi-asserted-by":"crossref","unstructured":"Alfredsson L, Olsson T (2019) Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harb Perspect Med 9(4)","DOI":"10.1101\/cshperspect.a028944"},{"issue":"3","key":"8187_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/WCO.0000000000000329","volume":"29","author":"AK Hedstr\u00f6m","year":"2016","unstructured":"Hedstr\u00f6m AK, Alfredsson L, Olsson T (2016) Environmental factors and their interactions with risk genotypes in MS susceptibility. Curr Opin Neurol 29(3):293\u2013298","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"8187_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1212\/CON.0000000000000725","volume":"25","author":"B Nourbakhsh","year":"2019","unstructured":"Nourbakhsh B, Mowry EM (2019) Multiple sclerosis risk factors and pathogenesis. Continuum (Minneap Minn) 25(3):596\u2013610","journal-title":"Continuum (Minneap Minn)"},{"key":"8187_CR7","doi-asserted-by":"crossref","unstructured":"Tarlinton RE, Khaibullin T, Granatov E, Martynova E, Rizvanov A, Khaiboullina S (2019) The interaction between viral and environmental risk factors in the pathogenesis of multiple sclerosis. Int J Mol Sci 20(2)","DOI":"10.3390\/ijms20020303"},{"issue":"9","key":"8187_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-009-9367-2","volume":"24","author":"C Ahlgren","year":"2009","unstructured":"Ahlgren C, Tor\u00e9n K, Od\u00e9n A, Andersen O (2009) A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Eur J Epidemiol 24(9):541\u2013552","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"8187_CR9","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00415-016-8263-4","volume":"264","author":"MT Mailand","year":"2017","unstructured":"Mailand MT, Frederiksen JL (2017) Vaccines and multiple sclerosis: a systematic review. J Neurol 264(6):1035\u20131050","journal-title":"J Neurol"},{"issue":"5","key":"8187_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200102013440502","volume":"344","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM (2001) Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 344(5):327\u2013332","journal-title":"N Engl J Med"},{"issue":"12","key":"8187_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/archpedi.161.12.1176","volume":"161","author":"Y Mikaeloff","year":"2007","unstructured":"Mikaeloff Y, Caridade G, Rossier M, Suissa S, Tardieu M (2007) Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med 161(12):1176\u20131182","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"8187_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1365-2893.2003.00423.x","volume":"10","author":"V Demicheli","year":"2003","unstructured":"Demicheli V, Rivetti A, Pietrantonj CD, Clements CJ, Jefferson T (2003) Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. J Viral Hepatitis 10(5):343\u2013344","journal-title":"J Viral Hepatitis"},{"issue":"4","key":"8187_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","volume":"22","author":"F Aloisi","year":"2023","unstructured":"Aloisi F, Giovannoni G, Salvetti M (2023) Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol 22(4):338\u2013349","journal-title":"Lancet Neurol"},{"issue":"6578","key":"8187_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375(6578):296\u2013301","journal-title":"Science"},{"issue":"3","key":"8187_CR15","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik K, M\u00fcnz C, Cohen JI, Ascherio A (2023) Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol 19(3):160\u2013171","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"8187_CR16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","volume":"63","author":"MA Hern\u00e1n","year":"2004","unstructured":"Hern\u00e1n MA, Jick SS, Olek MJ, Jick H (2004) Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology 63(5):838\u2013842","journal-title":"Neurology"},{"key":"8187_CR17","doi-asserted-by":"publisher","first-page":"103487","DOI":"10.1016\/j.msard.2022.103487","volume":"58","author":"S Akhtar","year":"2022","unstructured":"Akhtar S, El-Muzaini H, Alroughani R (2022) Recombinant hepatitis B vaccine uptake and multiple sclerosis risk: A marginal structural modeling approach. Multiple Scler Relat Disorders 58:103487","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"8187_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12883-020-01635-1","volume":"20","author":"H El-Muzaini","year":"2020","unstructured":"El-Muzaini H, Akhtar S, Alroughani R (2020) A matched case-control study of risk factors associated with multiple sclerosis in Kuwait. BMC Neurol 20(1):64","journal-title":"BMC Neurol"},{"issue":"1","key":"8187_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12883-020-01886-y","volume":"20","author":"H El-Muzaini","year":"2020","unstructured":"El-Muzaini H, Akhtar S, Alroughani R (2020) Correction to: A matched case-control study of risk factors associated with multiple sclerosis in Kuwait. BMC Neurol 20(1):306","journal-title":"BMC Neurol"},{"issue":"5","key":"8187_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1399-0004.1985.tb00236.x","volume":"27","author":"SA Al-Awadi","year":"1985","unstructured":"Al-Awadi SA, Moussa MA, Naguib KK, Farag TI, Teebi AS, el-Khalifa M (1985) el-Dossary, consanguinity among the Kuwaiti population. Clin Genet 27(5):483\u2013486","journal-title":"Clin Genet"},{"issue":"3","key":"8187_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5144\/0256-4947.1999.206","volume":"19","author":"Z Radovanovic","year":"1999","unstructured":"Radovanovic Z, Shah N, Behbehani J (1999) Prevalence and social correlates to consanguinity in Kuwait. Ann Saudi Med 19(3):206\u2013210","journal-title":"Ann Saudi Med"},{"issue":"5","key":"8187_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jiph.2021.01.015","volume":"14","author":"J Rezqalla","year":"2021","unstructured":"Rezqalla J, Alshatti M, Ibraheem A, Omar D, Houda AF, AlHaqqan S, AlGhurair S, Akhtar S (2021) Human papillomavirus (HPV): unawareness of the causal role of HPV infection in cervical cancer, HPV vaccine availability, and HPV vaccine uptake among female schoolteachers in a middle Eastern country. J Infect Public Health 14(5):661\u2013667","journal-title":"J Infect Public Health"},{"issue":"1","key":"8187_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000341240","volume":"40","author":"HH Al-Afasy","year":"2013","unstructured":"Al-Afasy HH, Al-Obaidan MA, Al-Ansari YA, Al-Yatama SA, Al-Rukaibi MS, Makki NI, Suresh A, Akhtar S (2013) Risk factors for multiple sclerosis in Kuwait: a population-based case-control study. Neuroepidemiology 40(1):30\u201335","journal-title":"Neuroepidemiology"},{"issue":"10","key":"8187_CR24","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/tmi.12556","volume":"20","author":"G Asiki","year":"2015","unstructured":"Asiki G, Stockdale L, Kasamba I, Vudriko T, Tumwekwase G, Johnston T, Kaleebu P, Kamali A, Seeley J, Newton R (2015) Pilot study of antibodies against varicella Zoster virus and human immunodeficiency virus in relation to the risk of developing stroke, nested within a rural cohort in Uganda. Trop Med Int Health 20(10):1306\u20131310","journal-title":"Trop Med Int Health"},{"key":"8187_CR25","doi-asserted-by":"publisher","first-page":"613366","DOI":"10.3389\/fonc.2020.613366","volume":"10","author":"Y Lu","year":"2020","unstructured":"Lu Y, Zhang W, Fan S, Liang Z, Li Z, Tian J, Kang J, Song Y, Liu K, Zhou K, Wang X, Yang Y, Liu X (2020) Metabolic syndrome and risk of upper tract urothelial carcinoma: A Case-Control study from surveillance, epidemiology and end Results-Medicare-Linked database. Front Oncol 10:613366","journal-title":"Front Oncol"},{"issue":"14","key":"8187_CR26","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/sim.3057","volume":"27","author":"JM Lachin","year":"2008","unstructured":"Lachin JM (2008) Sample size evaluation for a multiply matched case-control study using the score test from a conditional logistic (discrete Cox PH) regression model. Stat Med 27(14):2509\u20132523","journal-title":"Stat Med"},{"issue":"1","key":"8187_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","volume":"115","author":"S Lemeshow","year":"1982","unstructured":"Lemeshow S, Hosmer DW Jr. (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115(1):92\u2013106","journal-title":"Am J Epidemiol"},{"issue":"5","key":"8187_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a121617","volume":"99","author":"OS Miettinen","year":"1974","unstructured":"Miettinen OS (1974) Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 99(5):325\u2013332","journal-title":"Am J Epidemiol"},{"issue":"4","key":"8187_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2307\/2529268","volume":"32","author":"SD Walter","year":"1976","unstructured":"Walter SD (1976) The Estimation and interpretation of attributable risk in health research. Biometrics 32(4):829\u2013849","journal-title":"Biometrics"},{"issue":"7","key":"8187_CR30","doi-asserted-by":"publisher","first-page":"e0132106","DOI":"10.1371\/journal.pone.0132106","volume":"10","author":"SN Al-Shammri","year":"2015","unstructured":"Al-Shammri SN, Hanna MG, Chattopadhyay A, Akanji AO (2015) Sociocultural and demographic risk factors for the development of multiple sclerosis in Kuwait: A Case - Control study. PLoS ONE 10(7):e0132106","journal-title":"PLoS ONE"},{"issue":"7","key":"8187_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1474-4422(10)70094-6","volume":"9","author":"SV Ramagopalan","year":"2010","unstructured":"Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7):727\u2013739","journal-title":"Lancet Neurol"},{"key":"8187_CR32","doi-asserted-by":"publisher","first-page":"e1797","DOI":"10.7717\/peerj.1797","volume":"4","author":"P Zhang","year":"2016","unstructured":"Zhang P, Wang R, Li Z, Wang Y, Gao C, Lv X, Song Y, Li B (2016) The risk of smoking on multiple sclerosis: a meta-analysis based on 20,626 cases from case-control and cohort studies. PeerJ 4:e1797","journal-title":"PeerJ"},{"key":"8187_CR33","unstructured":"Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TM, Booth D, Buck D, Celius EG, Cotsapas C, D\u2019Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Lar Fugger L, Goris A, Gourraud PA, Graetz C, Hemmer B, Hillert J, Kockum I, Leslie S, Lill CM, Martinelli-Boneschi F, Oksenberg JR, Olsson T, Oturai A, Saarela J, Sondergaard HB, Spurkland A, Taylor B, Winkelmann J, Zipp F, Haines JL, Pericak-Vance MA, Spencer CC, Stewart G, Hafler DA, Ivinson AJ, Harbo HF, Hauser SL, De Jager PL, Compston A, McCauley JL, Sawcer S, McVean G (2015) Class II HLA interactions modulate genetic risk for multiple sclerosis, Nature genetics 47(10) 1107-13"},{"key":"8187_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","volume":"64","author":"JA Hollenbach","year":"2015","unstructured":"Hollenbach JA, Oksenberg JR (2015) The immunogenetics of multiple sclerosis: A comprehensive review. J Autoimmun 64:13\u201325","journal-title":"J Autoimmun"},{"key":"8187_CR35","doi-asserted-by":"crossref","unstructured":"Le H, de Klerk N, Blyth CC, Gidding H, Fathima P, Moore HC (2023) Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data, Vaccine","DOI":"10.1016\/j.vaccine.2023.06.085"},{"issue":"5","key":"8187_CR36","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/ene.15748","volume":"30","author":"K Berek","year":"2023","unstructured":"Berek K, Deisl P, Bichler M, Auer M, Barket R, Bauer A, Zinganell A, Di Pauli F, Deisenhammer F, Hegen H (2023) Immunization status in patients with multiple sclerosis: A cross-sectional, monocenter study in Austria. Eur J Neurol 30(5):1400\u20131408","journal-title":"Eur J Neurol"},{"issue":"2","key":"8187_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1212\/01.wnl.0000225079.51201.f9","volume":"67","author":"MA Hern\u00e1n","year":"2006","unstructured":"Hern\u00e1n MA, Alonso A, Hern\u00e1ndez-D\u00edaz S (2006) Tetanus vaccination and risk of multiple sclerosis: a systematic review. Neurology 67(2):212\u2013215","journal-title":"Neurology"},{"issue":"5","key":"8187_CR38","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.mehy.2005.05.009","volume":"65","author":"T Verstraeten","year":"2005","unstructured":"Verstraeten T, Davis R, DeStefano F (2005) Immunity to tetanus is protective against the development of multiple sclerosis. Med Hypotheses 65(5):966\u2013969","journal-title":"Med Hypotheses"},{"issue":"9","key":"8187_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","volume":"34","author":"CS Benn","year":"2013","unstructured":"Benn CS, Netea MG, Selin LK, Aaby P (2013) A small jab - a big effect: nonspecific Immunomodulation by vaccines. Trends Immunol 34(9):431\u2013439","journal-title":"Trends Immunol"},{"issue":"4","key":"8187_CR40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61(4):288\u2013299","journal-title":"Ann Neurol"},{"key":"8187_CR41","doi-asserted-by":"publisher","first-page":"i5170","DOI":"10.1136\/bmj.i5170","volume":"355","author":"JP Higgins","year":"2016","unstructured":"Higgins JP, Soares-Weiser K, L\u00f3pez-L\u00f3pez JA, Kakourou A, Chaplin K, Christensen H, Martin NK, Sterne JA, Reingold AL (2016) Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 355:i5170","journal-title":"BMJ"},{"issue":"3","key":"8187_CR42","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.amepre.2021.02.025","volume":"61","author":"F Chen","year":"2021","unstructured":"Chen F, Chen GX, Zhou J, Xue Y, Wu MX (2021) Childhood Bacille Calmette-Guerin vaccination and its association with less severe COVID-19 pneumonia. Am J Prev Med 61(3):e119\u2013e126","journal-title":"Am J Prev Med"},{"issue":"41","key":"8187_CR43","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1016\/j.vaccine.2020.08.018","volume":"38","author":"K Yitbarek","year":"2020","unstructured":"Yitbarek K, Abraham G, Girma T, Tilahun T, Woldie M (2020) The effect of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: implications for the COVID-19 pandemic. Vaccine 38(41):6374\u20136380","journal-title":"Vaccine"},{"issue":"10","key":"8187_CR44","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/ni.2961","volume":"15","author":"P Aaby","year":"2014","unstructured":"Aaby P, Kollmann TR, Benn CS (2014) Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges. Nat Immunol 15(10):895\u2013899","journal-title":"Nat Immunol"},{"issue":"10","key":"8187_CR45","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1016\/S1473-3099(19)30742-X","volume":"20","author":"CS Benn","year":"2020","unstructured":"Benn CS, Fisker AB, Rieckmann A, S\u00f8rup S, Aaby P (2020) Vaccinology: time to change the paradigm? Lancet Infect Dis 20(10):e274\u2013e283","journal-title":"Lancet Infect Dis"},{"issue":"1645","key":"8187_CR46","doi-asserted-by":"publisher","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","volume":"369","author":"B Greenwood","year":"2014","unstructured":"Greenwood B (2014) The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci 369(1645):20130433","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8187_CR47","doi-asserted-by":"crossref","unstructured":"Carvajal R, Tur C, Borras-Bermejo B, Saylor D, Montalban X, Tintor\u00e9 M, Otero-Romero S (2025) Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization, Multiple sclerosis (Houndmills, Basingstoke, England) 13524585251318513","DOI":"10.1177\/13524585251318513"},{"issue":"6","key":"8187_CR48","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1007\/s00415-022-11009-x","volume":"269","author":"AR Buonomo","year":"2022","unstructured":"Buonomo AR, Viceconte G, Calabrese M, De Luca G, Tomassini V, Cavalla P, Maniscalco GT, Ferraro D, Nociti V, Radaelli M, Buscarinu MC, Paolicelli D, Gajofatto A, Annovazzi P, Pinardi F, Di Filippo M, Cordioli C, Zappulo E, Scotto R, Gentile I, Spiezia AL, Petruzzo M, De Angelis M, Brescia Morra V, Solaro C, Gasperini C, Cocco E, Moccia M, Lanzillo R (2022) Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study. J Neurol 269(6):3301\u20133307","journal-title":"J Neurol"},{"key":"8187_CR49","doi-asserted-by":"publisher","first-page":"104490","DOI":"10.1016\/j.msard.2022.104490","volume":"70","author":"F Ladeira","year":"2023","unstructured":"Ladeira F, Oliveira T, Soares M, Araujo C, Sousa A, Brum M, Sequeira J, Capela C (2023) HBV and VZV seroprotection loss in MS patients under DMT. Multiple Scler Relat Disorders 70:104490","journal-title":"Multiple Scler Relat Disorders"},{"issue":"8","key":"8187_CR50","first-page":"904","volume":"29","author":"S Otero-Romero","year":"2023","unstructured":"Otero-Romero S, Lebrun-Fr\u00e9nay C, Reyes S, Amato MP, Campins M, Farez M, Filippi M, Hacohen Y, Hemmer B, Juuti R, Magyari M, Oreja-Guevara C, Siva A, Vukusic S, Tintor\u00e9 M (2023) ECTRIMS\/EAN consensus on vaccination in people with multiple sclerosis: improving immunization strategies in the era of highly active immunotherapeutic drugs, multiple sclerosis (Houndmills, Basingstoke. England) 29(8):904\u2013925","journal-title":"England)"},{"key":"8187_CR51","doi-asserted-by":"crossref","unstructured":"Bazmi E, Behnoush AH, Talebian MT, Afrooghe A, Sahraian MA (2024) Waterpipe Tobacco Smoking and Multiple Sclerosis: A Systematic Review and Meta-Analysis, Neuroepidemiology 1\u201311","DOI":"10.1159\/000540087"},{"key":"8187_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jocn.2024.02.013","volume":"122","author":"F Wahbeh","year":"2024","unstructured":"Wahbeh F, Restifo D, Laws S, Pawar A, Parikh NS (2024) Impact of tobacco smoking on disease-specific outcomes in common neurological disorders: A scoping review. J Clin Neurosci 122:10\u201318","journal-title":"J Clin Neurosci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08187-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08187-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08187-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:15:58Z","timestamp":1757160958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08187-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8187"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08187-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval of the study protocol was granted by Health Sciences Center Ethical Committee, Kuwait University and The Standing Committee for Coordination of Health and Medical Research, Ministry of Health, Kuwait. Written consent was obtained from each study participant after explaining the aims and potential benefits of the study, length of questionnaire and time required to answer all the questions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}